Minimally Invasive and Open Gastrectomy for Gastric Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
Gastrectomy
Gastric cancer
Minimally invasive surgery
Oncological outcomes
Surgical oncology
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
03
01
2023
accepted:
04
05
2023
medline:
11
8
2023
pubmed:
1
6
2023
entrez:
1
6
2023
Statut:
ppublish
Résumé
Optimal surgical management for gastric cancer remains controversial. We aimed to perform a network meta-analysis (NMA) of randomized clinical trials (RCTs) comparing outcomes after open gastrectomy (OG), laparoscopic-assisted gastrectomy (LAG), and robotic gastrectomy (RG) for gastric cancer. A systematic search of electronic databases was undertaken. An NMA was performed as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-NMA guidelines. Statistical analysis was performed using R and Shiny. Twenty-two RCTs including 6890 patients were included. Overall, 49.6% of patients underwent LAG (3420/6890), 46.6% underwent OG (3212/6890), and 3.7% underwent RG (258/6890). At NMA, there was a no significant difference in recurrence rates following LAG (odds ratio [OR] 1.09, 95% confidence interval [CI] 0.77-1.49) compared with OG. Similarly, overall survival (OS) outcomes were identical following OG and LAG (OS: OG, 87.0% [1652/1898] vs. LAG: OG, 87.0% [1650/1896]), with no differences in OS in meta-analysis (OR 1.02, 95% CI 0.77-1.52). Importantly, patients undergoing LAG experienced reduced intraoperative blood loss, surgical incisions, distance from proximal margins, postoperative hospital stays, and morbidity post-resection. LAG was associated with non-inferior oncological and surgical outcomes compared with OG. Surgical outcomes following LAG and RG superseded OG, with similar outcomes observed for both LAG and RG. Given these findings, minimally invasive approaches should be considered for the resection of local gastric cancer, once surgeon and institutional expertise allows.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Optimal surgical management for gastric cancer remains controversial. We aimed to perform a network meta-analysis (NMA) of randomized clinical trials (RCTs) comparing outcomes after open gastrectomy (OG), laparoscopic-assisted gastrectomy (LAG), and robotic gastrectomy (RG) for gastric cancer.
METHODS
METHODS
A systematic search of electronic databases was undertaken. An NMA was performed as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-NMA guidelines. Statistical analysis was performed using R and Shiny.
RESULTS
RESULTS
Twenty-two RCTs including 6890 patients were included. Overall, 49.6% of patients underwent LAG (3420/6890), 46.6% underwent OG (3212/6890), and 3.7% underwent RG (258/6890). At NMA, there was a no significant difference in recurrence rates following LAG (odds ratio [OR] 1.09, 95% confidence interval [CI] 0.77-1.49) compared with OG. Similarly, overall survival (OS) outcomes were identical following OG and LAG (OS: OG, 87.0% [1652/1898] vs. LAG: OG, 87.0% [1650/1896]), with no differences in OS in meta-analysis (OR 1.02, 95% CI 0.77-1.52). Importantly, patients undergoing LAG experienced reduced intraoperative blood loss, surgical incisions, distance from proximal margins, postoperative hospital stays, and morbidity post-resection.
CONCLUSIONS
CONCLUSIONS
LAG was associated with non-inferior oncological and surgical outcomes compared with OG. Surgical outcomes following LAG and RG superseded OG, with similar outcomes observed for both LAG and RG. Given these findings, minimally invasive approaches should be considered for the resection of local gastric cancer, once surgeon and institutional expertise allows.
Identifiants
pubmed: 37261563
doi: 10.1245/s10434-023-13654-6
pii: 10.1245/s10434-023-13654-6
pmc: PMC10409677
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5544-5557Informations de copyright
© 2023. The Author(s).
Références
Surg Endosc. 2013 Feb;27(2):599-602
pubmed: 22955998
Ann Surg. 2021 May 1;273(5):858-867
pubmed: 32889876
Cochrane Database Syst Rev. 2016 Mar 31;3:CD011389
pubmed: 27030300
Surg Endosc. 2013 Nov;27(11):4267-76
pubmed: 23793805
BMC Med. 2013 Jul 04;11:159
pubmed: 23826681
Crit Rev Oncol Hematol. 2022 Jul;175:103729
pubmed: 35662586
BMC Surg. 2017 Aug 24;17(1):93
pubmed: 28836986
Med Oncol. 2015 Oct;32(10):241
pubmed: 26350550
JAMA. 2019 May 28;321(20):1983-1992
pubmed: 31135850
Surg Endosc. 2019 Jan;33(1):33-45
pubmed: 30386984
J Am Coll Surg. 2010 Nov;211(5):677-86
pubmed: 20869270
Ann Surg. 2005 Feb;241(2):232-7
pubmed: 15650632
Ann Oncol. 2016 Sep;27(suppl 5):v38-v49
pubmed: 27664260
Gastric Cancer. 2017 Jan;20(1):1-19
pubmed: 27342689
Eur J Surg Oncol. 2020 Nov;46(11):1998-2010
pubmed: 32758382
Surg Endosc. 2005 Feb;19(2):168-73
pubmed: 15580441
Ann Surg Oncol. 2021 Aug;28(8):4151-4157
pubmed: 33689079
Curr Oncol. 2022 Mar 09;29(3):1840-1865
pubmed: 35323351
Int J Surg. 2022 Jun;102:106678
pubmed: 35589049
Ann Surg. 2019 Dec;270(6):983-991
pubmed: 30829698
Ann Surg. 2019 Dec;270(6):1096-1102
pubmed: 29995679
Stat Methods Med Res. 2018 Jun;27(6):1785-1805
pubmed: 27683581
J Gastrointest Surg. 2012 Oct;16(10):1830-9
pubmed: 22854954
J Endourol. 2013 Mar;27(3):298-303
pubmed: 22967039
Arch Surg. 2011 Sep;146(9):1086-92
pubmed: 21576595
Surgery. 2021 Sep;170(3):942-951
pubmed: 34023140
J Clin Oncol. 2016 Apr 20;34(12):1350-7
pubmed: 26903580
Gut. 2019 Sep;68(9):1545-1575
pubmed: 31278206
Res Synth Methods. 2019 Dec;10(4):569-581
pubmed: 31349391
WMJ. 1999 Mar-Apr;98(2):25-8
pubmed: 10235058
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Surg Endosc. 2005 Sep;19(9):1172-6
pubmed: 16132323
Medicina (Kaunas). 2021 Nov 03;57(11):
pubmed: 34833413
Ann Surg Oncol. 2014 Jun;21(6):1983-90
pubmed: 24499830
Robot Surg. 2019 Dec 23;6:27-40
pubmed: 31921934
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
Surg Endosc. 2019 Apr;33(4):1033-1048
pubmed: 30719561
Cancer Manag Res. 2018 Apr 10;10:705-714
pubmed: 29692629
Cochrane Database Syst Rev. 2017 Aug 29;8:CD004064
pubmed: 28850174
Br J Surg. 2020 Aug;107(9):1211-1220
pubmed: 32246472
Gastric Cancer. 2017 Jul;20(4):699-708
pubmed: 27718137
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
Updates Surg. 2022 Feb;74(1):267-281
pubmed: 34655427
Br J Anaesth. 2017 Dec 1;119(suppl_1):i72-i84
pubmed: 29161400
Ann Surg. 2015 Nov;262(5):803-7; discussion 807-8
pubmed: 26583669
Ann Gastroenterol Surg. 2022 Feb 25;6(3):336-343
pubmed: 35634188
Surg Endosc. 2002 Aug;16(8):1187-91
pubmed: 11984681
Dig Surg. 2011;28(5-6):331-7
pubmed: 21934308
Transl Gastroenterol Hepatol. 2020 Jan 05;5:11
pubmed: 32190779
Surg Today. 2016 Jun;46(6):741-9
pubmed: 26223834
JAMA Surg. 2019 Dec 1;154(12):1093-1101
pubmed: 31553463
Br J Surg. 2019 Aug;106(9):1120-1121
pubmed: 31304578
Surg Endosc. 2013 May;27(5):1695-705
pubmed: 23247737
Gastric Cancer. 2018 Mar;21(2):285-295
pubmed: 28639136
Ann Surg. 2018 Apr;267(4):638-645
pubmed: 28187041
World J Surg Oncol. 2020 Nov 24;18(1):306
pubmed: 33234134
Surg Endosc. 2018 May;32(5):2427-2433
pubmed: 29234941
Gastric Cancer. 2019 Jan;22(1):214-222
pubmed: 30128720
BMJ. 2014 Jul 08;349:g4198
pubmed: 25005264
JAMA Oncol. 2019 Apr 01;5(4):506-513
pubmed: 30730546
JAMA. 2012 Sep 26;308(12):1246-53
pubmed: 23011714
Ann Gastroenterol Surg. 2017 Jul 28;1(2):82-89
pubmed: 29863139
Obes Surg. 2021 Feb;31(2):854-861
pubmed: 33165753
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Restor Dent Endod. 2017 May;42(2):152-155
pubmed: 28503482
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):142-151
pubmed: 31757656
Surg Laparosc Endosc. 1994 Apr;4(2):146-8
pubmed: 8180768
J Clin Oncol. 2021 Mar 20;39(9):978-989
pubmed: 34581617
J Gastric Cancer. 2012 Sep;12(3):156-63
pubmed: 23094227
Ann Surg. 2016 Jan;263(1):28-35
pubmed: 26352529
Ann Surg. 2008 Nov;248(5):721-7
pubmed: 18948798
Ann Surg. 2021 Mar 1;273(3):467-473
pubmed: 32398482
Updates Surg. 2017 Jun;69(2):127-133
pubmed: 28497219
World J Gastroenterol. 2014 Oct 21;20(39):14280-91
pubmed: 25339815
CA Cancer J Clin. 2021 May;71(3):264-279
pubmed: 33592120
JAMA Surg. 2021 Oct 1;156(10):954-963
pubmed: 34468701
Oncol Lett. 2021 Jun;21(6):467
pubmed: 33907577
World J Surg. 2013 Oct;37(10):2379-86
pubmed: 23783252
BJS Open. 2020 Feb;4(1):27-44
pubmed: 32011823
J Clin Oncol. 2020 Oct 1;38(28):3304-3313
pubmed: 32816629